Clinical Trial Update: Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of abemaciclib in metastatic or locally advanced anaplastic/undifferentiated thyroid cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer
• Thyroid Cancer
• Undifferentiated Thyroid Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Stanford University | Conditions: Thyroid Cancer, Anaplastic Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19